Dr. Raje on Remaining Questions in Multiple Myeloma

Noopur S. Raje, MD, discusses remaining questions in multiple myeloma. 

Noopur S. Raje, MD, professor of medicine at Harvard Medical School and director of the Multiple Myeloma Program at Massachusetts General Hospital, discusses remaining questions in multiple myeloma. 

On the heels of recent advances with BCMA-directed therapies, future research efforts should focus on developing novel combination​s and ​refining sequencing strategies, says Raje. 

Additionally, smoldering myeloma remains an area of controversy, Raje explains. ​Eliminating the definition of smoldering myeloma, and instead focusing on whether a patient has myeloma, could help streamline the treatment algorithm.

Ultimately, better risk stratification is critical, Raje concludes. 

Related Videos
Brian A. Van Tine, MD, PhD
Jason Luke, MD, FACP
Katherine B. Peters, MD, PhD
Yasushi Goto, MD
Prithviraj Bose, MD, associate professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Jun Ma, MD
Hussein A. Tawbi, MD, PhD
Katsumori Asai, MD, PhD
Bernard Doger de Spéville, MD, PhD
Related Content